ArticlePLoS computational biology2025
Improving cell-type composition inference in spatial transcriptomics with SpaDAMA.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- st2traj: deconvolution-informed trajectory inference for multi-timepoint spatial transcriptomics.Bioinformatics (Oxford, England) · 2026Article
- PRISM: Prior-enhanced Inference for Spatial Transcriptomic Cell Type Mapping.Bioinformatics (Oxford, England) · 2026Article
- NicheDeSig: niche-aware deconvolution and adaptive signature analysis for spatial transcriptomics.Bioinformatics (Oxford, England) · 2026Article
- Reconstructing cell-cell interaction network in single-cell spatial transcriptomics via directed heterogeneous graph autoencoder.Bioinformatics (Oxford, England) · 2026Article
- STransfer: a transfer learning-enhanced graph convolutional network for clustering spatial transcriptomics data.Bioinformatics (Oxford, England) · 2026Article
- So3D: a comprehensive three-dimensional spatial omics resource for decoding tissue architecture in physiology and disease.Nucleic acids research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Accurate determination of cell-type composition in disease-relevant tissues is essential for identifying potential disease targets and understanding tissue heterogeneity. Most current spatial transcriptomics (ST) technologies lack single-cell resolution, which makes precise cell-type composition identification challenging. Several deconvolution methods have been developed to address this limitation by relying on single-cell RNA sequencing (scRNA-seq) data from the same tissue as a reference to estimate the cell type composition in ST data spots. However, these methods often overlook the inherent differences between scRNA-seq and ST data. To overcome this challenge, we introduce a Domain-Adversarial Masked Autoencoder (SpaDAMA) method. SpaDAMA leverages Domain-Adversarial Learning (DAL) to facilitate effective knowledge transfer from the source domain (pseudo-ST data generated from scRNA-seq) to the target domain (real ST data). Through adversarial training, SpaDAMA harmonizes the distributions of both datasets and maps them onto a unified latent representation, thereby reducing discrepancies in data modalities. Furthermore, to strengthen the model's capability in extracting reliable features from real ST data, SpaDAMA employs masking strategies that effectively minimize noise and mitigate spatial artifacts. We validated SpaDAMA on 32 simulated datasets and 4 real-world datasets, demonstrating its superior performance in cell-type deconvolution and providing a promising tool for spatial transcriptomic analyses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.